EVEREST MED-B (01952) issues stock purchase rights and rewards

Everest Med-B (01952) announced that on April 1, 2025, the board of directors (i) granted 4.4515 million stock options under the first public offering post-ipo share purchase plan, (ii) granted 1.1504 million incentives under the first public offering pre-ipo employee stock purchase plan, and (iii) granted 0.5517 million performance target incentives under the first public offering pre-ipo employee stock purchase plan.